$IDXX IDEXX LABORATORIES INC /DE Insider Trading Week 33/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IDEXX LABORATORIES INC /DE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in IDEXX LABORATORIES INC /DE in week 33/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21 2020 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | M | 63.95 | 3,722 | 238,022 | 0 | |
| Aug 21 2020 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Sell | S | 382.61 | 3,722 | 1,424,063 | 2,847 | 6.6 K to 2.8 K (-56.66 %) |
| Aug 21 2020 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Buy | M | 63.95 | 3,722 | 238,022 | 6,569 | 2.8 K to 6.6 K (+130.73 %) |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | CVP, Gen. Counsel & ... | Option Exercise | M | 206.94 | 483 | 99,952 | 1,932 | |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | CVP, Gen. Counsel & ... | Buy | M | 206.94 | 483 | 99,952 | 874 | 391 to 874 (+123.53 %) |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 79.54 | 1,256 | 99,902 | 0 | |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 53.19 | 1,880 | 99,988 | 0 | |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 79.54 | 1,256 | 99,902 | 52,732 | 51.5 K to 52.7 K (+2.44 %) |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 53.19 | 1,880 | 99,988 | 51,486 | 49.6 K to 51.5 K (+3.79 %) |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Option Exercise | M | 67.85 | 20,000 | 1,357,000 | 177,954 | |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 386.40 | 100 | 38,640 | 810,467 | 810.6 K to 810.5 K (-0.01 %) |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 385.60 | 7,383 | 2,846,902 | 810,567 | 818 K to 810.6 K (-0.90 %) |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 384.94 | 4,477 | 1,723,394 | 817,950 | 822.4 K to 818 K (-0.54 %) |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 383.81 | 4,461 | 1,712,175 | 822,487 | 826.9 K to 822.5 K (-0.54 %) |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 382.28 | 3,579 | 1,368,184 | 826,888 | 830.5 K to 826.9 K (-0.43 %) |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Buy | M | 67.85 | 20,000 | 1,357,000 | 830,467 | 810.5 K to 830.5 K (+2.47 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 62.00 | 37,098 | 2,300,076 | 0 | |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 53.19 | 37,836 | 2,012,308 | 0 | |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 43.68 | 8,790 | 383,947 | 0 | |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 381.48 | 3,049 | 1,163,118 | 49,596 | 52.6 K to 49.6 K (-5.79 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 380.12 | 14,469 | 5,499,962 | 52,645 | 67.1 K to 52.6 K (-21.56 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 379.20 | 37,209 | 14,109,701 | 67,114 | 104.3 K to 67.1 K (-35.67 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 377.84 | 28,997 | 10,956,290 | 104,323 | 133.3 K to 104.3 K (-21.75 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 62.00 | 37,098 | 2,300,076 | 133,320 | 96.2 K to 133.3 K (+38.55 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 53.19 | 37,836 | 2,012,308 | 96,222 | 58.4 K to 96.2 K (+64.80 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 43.68 | 8,790 | 383,947 | 58,386 | 49.6 K to 58.4 K (+17.72 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | M | 67.85 | 1,107 | 75,110 | 769 | |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | M | 79.54 | 698 | 55,519 | 0 | |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Buy | M | 67.85 | 1,107 | 75,110 | 9,652 | 8.5 K to 9.7 K (+12.95 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Buy | M | 79.54 | 698 | 55,519 | 8,545 | 7.8 K to 8.5 K (+8.90 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Sell | S | 377.51 | 100 | 37,751 | 7,847 | 7.9 K to 7.8 K (-1.26 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Sell | S | 377.50 | 2,676 | 1,010,190 | 7,947 | 10.6 K to 7.9 K (-25.19 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Option Exercise | M | 70.54 | 5,629 | 397,070 | 0 | |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Sell | S | 385.11 | 5,629 | 2,167,803 | 304 | 5.9 K to 304 (-94.88 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Buy | M | 70.54 | 5,629 | 397,070 | 5,933 | 304 to 5.9 K (+1,851.64 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Sell | S | 378.08 | 1,111 | 420,047 | 304 | 1.4 K to 304 (-78.52 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Option Exercise | M | 62.00 | 19,940 | 1,236,280 | 0 | |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Option Exercise | M | 62.00 | 25,000 | 1,550,000 | 19,940 | |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 384.48 | 2,379 | 914,680 | 810,467 | 812.8 K to 810.5 K (-0.29 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 383.66 | 5,704 | 2,188,415 | 812,847 | 818.6 K to 812.8 K (-0.70 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 382.86 | 11,857 | 4,539,507 | 818,550 | 830.4 K to 818.6 K (-1.43 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Buy | M | 62.00 | 19,940 | 1,236,280 | 830,407 | 810.5 K to 830.4 K (+2.46 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 384.19 | 256 | 98,353 | 810,467 | 810.7 K to 810.5 K (-0.03 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 383.44 | 200 | 76,688 | 810,723 | 810.9 K to 810.7 K (-0.02 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 382.68 | 128 | 48,982 | 810,923 | 811.1 K to 810.9 K (-0.02 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 381.53 | 1,877 | 716,137 | 811,051 | 812.9 K to 811.1 K (-0.23 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 380.26 | 1,816 | 690,550 | 812,928 | 814.7 K to 812.9 K (-0.22 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 379.26 | 14,423 | 5,470,011 | 814,744 | 829.2 K to 814.7 K (-1.74 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 377.93 | 6,300 | 2,380,959 | 829,167 | 835.5 K to 829.2 K (-0.75 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Buy | M | 62.00 | 25,000 | 1,550,000 | 835,467 | 810.5 K to 835.5 K (+3.08 %) |